
Causes of antibiotic shortages and the solutions to address them – by Enrico Baraldi
10 February 2021
Monitoring antimicrobial resistance in Ghana: a focus on the hospital environment – by Abiola Isawumi and Lydia Mosi
18 January 2021
Learning from IPC strategies for COVID-19 to mitigate AMR in rural Nigerian communities – by Rachael Osagie
9 December 2020
The antibiotic R&D landscape in Japan – by Norio Ohmagari
25 November 2020
Why are new antibacterials failing as commercial products? – by Patricia A. Bradford
19 November 2020
COVID-19: Coinfection, secondary bacterial infections and AMR in India – by Venkatasubramanian Ramasubramanian
12 November 2020
Running a phase 3 trial for a new drug for gonorrhoea during the coronavirus pandemic – by Markus Heep, Esther Bettiol, Tanyaporn Wansom ...
15 October 2020
A lesson learned from COVID-19: The importance of non-inferiority (NI) trials for developing new antimicrobial agents before widespread need ...
6 October 2020